Market analysis identifies key players in endoscopic weight loss therapy through 2030

ResearchAndMarkets.com has released a competitive analysis focusing on the major participants in the endoscopic weight loss therapy market. The report evaluates companies such as Apollo Endosurgery, Allurion Technologies, ReShape Lifesciences, and Spatz Medical, assessing their contributions to non-surgical obesity management.

The findings center on technologies designed to emulate the metabolic effects of traditional bypass surgery with significantly less invasiveness. Innovations listed in the analysis include adjustable gastric balloons, swallowable capsule-based systems, and specialized endoscopic suturing platforms, all intended to improve patient outcomes and recovery times.

Market growth is attributed to increasing demand for clinical alternatives that avoid traditional surgery. The analysis underscores the necessity for firms to maintain robust clinical validation, regulatory compliance, and physician training programs to sustain market standing.

This research provides an overview of current competitive dynamics and serves as a tool for stakeholders navigating the shift toward value-based care in bariatric medicine.